|
⚲
|
| Trinity Biosystems Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001186197 |
| Sale | 2009-05-15 ($12.5 M Offered, $7.5 M Sold) |
| Fund | |
| Phone | 6505660780 |
| Address | 1490 Obrien Avenue Menlo Park, 94025 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Rene Kuijten | |
| Michael Diem | |
| Amin Khan | |
| S Torres | |
| Peter McWilliams | |
| Gail Maderis | |
| Helen Kim |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
New Columbia Owner LLC
✚
|
0.0 | |
|
Newcomb Brent
✚
|
0.0 | |
|
Newcomb Nancy
✚
|
0.0 | |
|
New Community Transformation Fund, LP
✚
|
0.0 | |
|
New Deal Distillery LLC
✚
|
0.0 | |
|
New England Refractory
✚
|
0.0 | |
|
New Era Capital Partners II, L.P.
✚
|
0.0 | |
|
New Era Energy Fund LP
✚
|
0.0 | |
|
Newfield Design, Inc.
✚
|
0.0 | |
|
LS Distressed XI ASP Fund, a series of Alternative Strategie
✚
|
0.0 |